Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Keratosis, Actinic 6Carcinoma, Basal Cell 4Uterine Cervical Dysplasia 3Squamous Intraepithelial Lesions 2HIV Infections 2Condylomata Acuminata 2Precancerous Conditions 1Patient Satisfaction 1Papillomavirus Infections 1Paget Disease, Extramammary 1Hutchinson's Melanotic Freckle 1Carcinoma, Squamous Cell 1Anus Neoplasms 1Acquired Immunodeficiency Syndrome 1

Interventions

Lidocaine 1Imiquimod 1Acetaminophen 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Paget Disease, Extramammary × Imiquimod × Clear all
NCT02385188 2020-01-02

Topical 5% Imiquimod Cream for Vulvar Paget's Disease

University Medical Center Nijmegen

Phase 3 Completed
25 enrolled

Paget Disease, Extramammary

Data powered by HemOnc (CC BY 4.0) Colophon âš¡